GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (OSTO:IMP A SDB) » Definitions » Price-to-Tangible-Book

Implantica AG (OSTO:IMP A SDB) Price-to-Tangible-Book : (As of Jul. 24, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Implantica AG Price-to-Tangible-Book?

As of today (2025-07-24), Implantica AG's share price is kr71.10. Implantica AG's Tangible Book per Share of . 20 for the quarter that ended in . 20 was kr0.00. Hence, Implantica AG's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Implantica AG's Price-to-Tangible-Book or its related term are showing as below:

OSTO:IMP A SDB's Price-to-Tangible-Book is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.78
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Implantica AG's share price is kr71.10. Implantica AG's Book Value per Sharefor the quarter that ended in . 20 was kr0.00. Hence, Implantica AG's P/B Ratio of today is .


Implantica AG Price-to-Tangible-Book Historical Data

The historical data trend for Implantica AG's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Implantica AG Price-to-Tangible-Book Chart

Implantica AG Annual Data
Trend
Price-to-Tangible-Book

Implantica AG Semi-Annual Data
Price-to-Tangible-Book

Competitive Comparison of Implantica AG's Price-to-Tangible-Book

For the Medical Devices subindustry, Implantica AG's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Implantica AG's Price-to-Tangible-Book Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Implantica AG's Price-to-Tangible-Book falls into.


;
;

Implantica AG Price-to-Tangible-Book Calculation

Implantica AG's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: . 20 )
=71.10/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Implantica AG Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Implantica AG's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Implantica AG Business Description

Comparable Companies
Traded in Other Exchanges
Address
Aeulestrasse 45, Vaduz, LIE, 9490
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing advanced technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected, product pipeline based partly on its two platform technologies. Its lead product, RefluxStop, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results.

Implantica AG Headlines

No Headlines